INS and early-onset autosomal dominant Alzheimer disease: More and more research is focusing on the role IDE (insulin-degrading enzyme) in modulate insulin level, arising amyloid β (Aβ) and development of cognitive impairment characteristic for the type 2 diabetes mellitus (T2DM) and Alzheimer’s disease.